AMBIJECT

pharmaceutical preparations, namely, biopharmaceuticals based on human monoclonal antibodies for the treatment of immune and inflammatory diseases and disorders, cardiovascular diseases and disorders, metabolic diseases and disorders, and infectious-related diseases and disorders

syringes for medical purposes and for injections, excluding syringes for the treatment of central nervous system disorders including Multile Sclerosis